J Wedgwood
Overview
Explore the profile of J Wedgwood including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
304
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hall 3rd R, Fairley J, Woodley D, Werth V, Hannah D, Streilein R, et al.
Br J Dermatol
. 2014 Aug;
172(3):760-8.
PMID: 25123295
Background: Pemphigus vulgaris (PV) is a blistering disease and tumour necrosis factor-α has a role in its pathogenesis. Objectives: To evaluate the safety of infliximab (IFX) with prednisone compared with...
2.
3.
McCormack J, Kelly K, Wedgwood J, Lyon R
Anaesthesia
. 2008 Aug;
63(8):814-21.
PMID: 18699897
Ventilatory impairment may be detected by a rise in transcutaneous carbon dioxide levels (PtcCO(2)). This observational study assessed the clinical utility of PtcCO(2) monitoring in the postoperative period, and quantified...
4.
Bateman R, Wedgwood J, Henning J
J R Nav Med Serv
. 2005 Jul;
91(1):48-9.
PMID: 15986842
During a recent deployment to Iraq, it was noticed that patients' recovery times from general anaesthesia were significantly prolonged. We postulated that this was because of a lack of nitrous...
5.
Cryz Jr S, Lang A, Rudeberg A, Wedgwood J, Que J, Furer E, et al.
Behring Inst Mitt
. 1997 Feb;
(98):345-9.
PMID: 9382759
Healthy, non-colonized cystic fibrosis (CF) patients (N = 26) were immunized with an octavalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. Vaccination was well tolerated and induced anti-lipopolysaccharide (LPS) antibodies of...
6.
Schaad U, Wedgwood J, Ruedeberg A, Kraemer R, Hampel B
Pediatr Infect Dis J
. 1997 Jan;
16(1):106-11; discussion 123-6.
PMID: 9002119
Objective: The efficacy and safety of oral ciprofloxacin as a maintenance antipseudomonal therapy were evaluated in 44 patients with cystic fibrosis who had completed a 14-day regimen of intensive hospital...
7.
Schaefer H, Stass H, Wedgwood J, Hampel B, Fischer C, Kuhlmann J, et al.
Antimicrob Agents Chemother
. 1996 Jan;
40(1):29-34.
PMID: 8787874
The pharmacokinetic characteristics of ciprofloxacin were studied in 10 children with cystic fibrosis, aged from 6 to 16 years, who had completed the standard regimen of intravenous ceftazidime and amikacin....
8.
Lang A, Schaad U, Rudeberg A, Wedgwood J, Que J, Furer E, et al.
J Pediatr
. 1995 Nov;
127(5):711-7.
PMID: 7472821
Patients with cystic fibrosis (CF; N = 26) and with no prior history of infection with Pseudomonas aeruginosa were immunized with an octavalent O-polysaccharide-toxin A conjugate vaccine. During the next...
9.
Cryz Jr S, Wedgwood J, Lang A, Ruedeberg A, Que J, Furer E, et al.
J Infect Dis
. 1994 May;
169(5):1159-62.
PMID: 8169414
The long-term safety and immunogenicity of a polyvalent Pseudomonas aeruginosa conjugate vaccine was evaluated in 30 noncolonized cystic fibrosis patients. Four doses were administered over 3 years, and patients were...
10.
Schaad U, Lips U, Gnehm H, Blumberg A, Heinzer I, Wedgwood J
Lancet
. 1993 Aug;
342(8869):457-61.
PMID: 8102428
Routine use of steroids as adjunctive treatment of bacterial meningitis remains controversial. We have carried out a prospective, placebo-controlled, double-blind study of dexamethasone in 115 children with acute bacterial meningitis...